CorMedix (CRMD) Return on Sales (2013 - 2025)

CorMedix (CRMD) has 12 years of Return on Sales data on file, last reported at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Sales fell 1.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (up 1.0% YoY), and the FY2025 full-year result was 0.0%, up 1.0% from the prior year.
• Return on Sales eased to 0.0% in Q4 2025, from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q3 2025 to a low of 10.69% in Q1 2022.
• A 4-year average of 2.59% and a median of 1.71% in 2021 frame the typical range for Return on Sales.
• Peak annual rise in Return on Sales reached 208 bps in 2022, while the deepest fall reached 873 bps in 2022.
• Tracing CRMD's Return on Sales over 4 years: stood at 1.71% in 2021, then slumped by 61 bps to 2.76% in 2022, then surged by 100 bps to 0.0% in 2024, then sank by 121 bps to 0.0% in 2025.
• Business Quant data shows CRMD's Return on Sales at 0.0% in Q4 2025, 0.01% in Q3 2025, and 0.0% in Q2 2025.